Crescita Announces Filing and Mailing of Special Meeting Materials and Receipt of Interim Order in respect of Arrangement with ClinActiv Holdings

Stock Information for Crescita Therapeutics Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Crescita Therapeutics Inc

Crescita Reports Q4 and Fiscal 2025 Results
Crescita Announces Definitive Agreement to Be Acquired by ClinActiv Holdings in an All-Cash Transaction at a Significant Premium
Crescita Reports Third Quarter 2025 Results
Crescita Reports Second Quarter 2025 Results
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
Crescita Therapeutics Announces Mutual Termination of Licensing Agreement with Croma Pharma GmbH for Pliaglis®
Crescita Reports First Quarter 2025 Results
Crescita Reports Q4 and Fiscal 2024 Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.